Established alternatives, like gonadotropin-releasing hormone (GnRH) agonists, oral contraceptives, and hormonal intrauterine devices (IUDs), have better safety and efficacy profile for conditions such as endometriosis and uterine fibroids. This evidence concerns the gene GNRH1 and endometriosis.